Divalproex Sodium Tablet, Film Coated, Extended Release
Product Images NDC 60687-915

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 60687-915). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

250 mg Divalproex Sodium Er Tablet Blister.jpg (250 mg Divalproex Sodium Er Tablet Blister)

Divalproex sodium 250 mg extended-release film-coated oral tablets label by American Health Packaging. The label includes dosage strength, lot number (1234567), expiration date (2025-06-19), and a barcode with expiration of 2025-06-19.*

FDA Label Image

250 mg Divalproex Sodium Er Tablets Carton.jpg (250 mg Divalproex Sodium Er Tablets Carton)

Label for divalproex sodium 250 mg extended-release oral tablets. The label states once-daily dosing and a package size of 100 film-coated tablets (10 x 10). It includes storage instructions, dispensing notes, and product distribution information by American Health Packaging. Barcode and QR code for medication guide and prescribing information are present.*

FDA Label Image

500 mg Divalproex Sodium Er Tablet Blister 100ud.jpg (500 mg Divalproex Sodium Er Tablet Blister 100ud)

Label for divalproex sodium extended-release tablets, USP, 500 mg strength. The label indicates once-daily dosing and includes lot number 1234567 with an expiration date of 2025-06-16. The product is a film-coated, extended-release oral tablet supplied by American Health Packaging. Multiple identical labels are shown on a single sheet.*

FDA Label Image

500 mg Divalproex Sodium Er Tablet Blister 80ud.jpg (500 mg Divalproex Sodium Er Tablet Blister 80ud)

Divalproex sodium 500 mg extended-release film-coated tablets packaging label from American Health Packaging. The label includes dosage form, strength, lot number 1234567, and expiration date 2025-07-09. Packaging also features the American Health Packaging logo and barcode.*

FDA Label Image

500 mg Divalproex Sodium Er Tablets Carton 100ud.jpg (500 mg Divalproex Sodium Er Tablets Carton 100ud)

Label for Divalproex Sodium Extended-Release Tablets 500 mg by American Health Packaging. The label indicates a once-daily dosing with a 100-tablet (10 x 10) package. It highlights valproic acid activity and includes the NDC number 60687-915-01. Additional pharmacist instructions and storage conditions are provided, along with a QR code for medication guide and prescribing information.*

FDA Label Image

500 mg Divalproex Sodium Er Tablets Carton 80ud.jpg (500 mg Divalproex Sodium Er Tablets Carton 80ud)

Label for Divalproex Sodium Extended-Release Tablets, USP, 500 mg film-coated tablets in an 80-count package (10 x 8). Manufactured by American Health Packaging, the label highlights once-daily dosing, Rx only status, and includes NDC 60687-915-02, barcode, pharmacist dispensing instructions, and storage information.*

FDA Label Image

Image (546b07bd 7dba 49c9 8caf 7914600d4d19 01)

Chemical structure of divalproex sodium showing the repeating units of its polymeric form, including sodium (Na+) and hydrogen (H+) ions associated with carboxylate groups.*

FDA Label Image

Image (546b07bd 7dba 49c9 8caf 7914600d4d19 02)

A line graph depicting the percentage reduction in CPS (Clinical Parameter Score) rate versus the percentage of patients, comparing divalproex sodium delayed-release tablets to a placebo. The graph shows improvement and worsening on the vertical axis, with the divalproex sodium group represented by a solid line and the placebo by a dashed line.*

FDA Label Image

Image (546b07bd 7dba 49c9 8caf 7914600d4d19 03)

A line graph depicting the percentage reduction in CPS rate versus the percentage of patients for high dose and low dose divalproex sodium delayed-release tablets. The vertical axis shows improvement or worsening in CPS rate, and the horizontal axis represents percentage of patients, illustrating comparative effectiveness of the two dosages.*

FDA Label Image

Image (546b07bd 7dba 49c9 8caf 7914600d4d19 04)

A bar chart comparing the effect of placebo versus divalproex sodium extended-release tablets. The chart shows values on the vertical axis ranging from 0 to 1.2, with a higher bar for divalproex sodium indicating a value of 1.2, versus the placebo bar showing 0.6. A significance marker notes a p-value of 0.006.*

FDA Label Image

Ahp90401

Divalproex sodium 250 mg or 500 mg extended-release film-coated tablet, oval and pink, imprinted with 'U 380' on one side. The other side is plain. The tablets are oral dosage form, manufactured or labeled by American Health Packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.